Published: Jul. 22, 2020 at 11:35 PM EDT|Updated: 11 hours ago
KNOXVILLE, Tenn. (WVLT) – COVID-19 cases continue to rise, which puts the pressure on business managers developing reopening plans. A Knoxville lab, which normally researches early cancer detection products, switched gears to help some of these businesses.
“We want to try to get back to normal as soon as possible,” Eric Mayer, the CEO of EDP Biotech in West Knoxville, said. “We want things to stay open and not go the other way. But we’ve got to make sure we’re doing it smart and making data-driven decisions.”
EDP Biotech is using their lab to help develop those data-driven decisions using COVID-19 antibody tests.
WATCH VIDEO and read the full article HERE!
